British Journal of Cancer - Table of Contents alert Volume 107 Issue 12

TABLE OF CONTENTS Volume 107, Issue 12 (1917-2038) Published online 4 December 2012 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Retraction Indexes Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients. Visit the journal online at www.bjcancer.com to view the latest research and access selected articles FREE of charge.   Clinical Studies Top Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study G S Ogilvie, M Krajden, D J van Niekerk, R E Martin, T G Ehlen, K Ceballos, L W Smith, L Kan, D A Cook, S Peacock, G C E Stuart, E L Franco and A J Coldman Br J Cancer 2012 107: 1917-1924; advance online publication, November 20, 2012; 10.1038/bjc.2012.489 Abstract | Full Text Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography T D Reid, D S Y Chan, S A Roberts, T D L Crosby, G T Williams and W G Lewis Br J Cancer 2012 107: 1925-1931; advance online publication, November 20, 2012; 10.1038/bjc.2012.511 Abstract | Full Text A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial Z Saridaki, N Androulakis, N Vardakis, L Vamvakas, E Kabouraki, K Kalbakis, D Hatzidaki, A Voutsina, D Mavroudis, V Georgoulias and J Souglakos Br J Cancer 2012 107: 1932-1937; advance online publication, November 20, 2012; 10.1038/bjc.2012.509 Abstract | Full Text Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation J Waller, A Macedo, C von Wagner, A E Simon, C Jones, V Hammersley, D Weller, J Wardle and C Campbell Br J Cancer 2012 107: 1938-1943; advance online publication, November 22, 2012; 10.1038/bjc.2012.512 Abstract | Full Text Translational Therapeutics Top CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver E Guillemot, B Karimdjee-Soilihi, E Pradelli, M Benchetrit, E Goguet-Surmenian, M-A Millet, F Larbret, J-F Michiels, D Birnbaum, P Alemanno, H Schmid-Antomarchi and A Schmid-Alliana Br J Cancer 2012 107: 1944-1949; advance online publication, November 20, 2012; 10.1038/bjc.2012.503 Abstract | Full Text Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer H Baba, M Watanabe, H Okabe, Y Miyamoto, Y Sakamoto, Y Baba, M Iwatsuki, A Chikamoto and T Beppu Br J Cancer 2012 107: 1950-1955; advance online publication, November 20, 2012; 10.1038/bjc.2012.502 Abstract | Full Text Molecular Diagnostics Top Role of IL-12p40 in cervical carcinoma H J M A A Zijlmans, S Punt, G J Fleuren, J B Trimbos, G G Kenter and A Gorter Br J Cancer 2012 107: 1956-1962; advance online publication, October 25, 2012; 10.1038/bjc.2012.488 Abstract | Full Text A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasis I V Bijnsdorp, L Rozendaal, R J A van Moorselaar and A A Geldof Br J Cancer 2012 107: 1963-1968; advance online publication, November 20, 2012; 10.1038/bjc.2012.500 Abstract | Full Text High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma K Niimi, E Yamamoto, S Fujiwara, K Shinjo, T Kotani, T Umezu, H Kajiyama, K Shibata, K Ino and F Kikkawa Br J Cancer 2012 107: 1969-1977; advance online publication, November 20, 2012; 10.1038/bjc.2012.496 Abstract | Full Text Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells M A Hoda, J Münzker, B Ghanim, K Schelch, T Klikovits, V Laszlo, E Sahin, A Bedeir, A Lackner, B Dome, U Setinek, M Filipits, M Eisenbauer, I Kenessey, S Török, T Garay, B Hegedus, A Catania, S Taghavi, W Klepetko, W Berger and M Grusch Br J Cancer 2012 107: 1978-1986; advance online publication, November 20, 2012; 10.1038/bjc.2012.519 Abstract | Full Text Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma C I Jones, M V Zabolotskaya, A J King, H J S Stewart, G A Horne, T J Chevassut and S F Newbury Br J Cancer 2012 107: 1987-1996; advance online publication, November 20, 2012; 10.1038/bjc.2012.525 Abstract | Full Text Genetics & Genomics Top KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer E Birkeland, E Wik, S Mjøs, E A Hoivik, J Trovik, H M J Werner, K Kusonmano, K Petersen, M B Raeder, F Holst, A M Øyan, K-H Kalland, L A Akslen, R Simon, C Krakstad and H B Salvesen Br J Cancer 2012 107: 1997-2004; advance online publication, October 25, 2012; 10.1038/bjc.2012.477 Abstract | Full Text The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers J Iqbal, A Ragone, J Lubinski, H T Lynch, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen, S L Neuhausen, L Senter, C F Singer, P Ainsworth, C Kim-Sing, N Tung, E Friedman, M Llacuachaqui, S Ping and S A Narod , the Hereditary Breast Cancer Study Group Br J Cancer 2012 107: 2005-2009; advance online publication, October 25, 2012; 10.1038/bjc.2012.483 Abstract | Full Text Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection C-M Chu, C-C Lin, Y-C Chen, W-J Jeng, S-M Lin and Y-F Liaw Br J Cancer 2012 107: 2010-2015; advance online publication, October 18, 2012; 10.1038/bjc.2012.474 Abstract | Full Text Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality S Masuda, T Kadowaki, N Kumaki, X Tang, Y Tokuda, S Yoshimura, S Takekoshi and R Y Osamura Br J Cancer 2012 107: 2016-2023; advance online publication, November 20, 2012; 10.1038/bjc.2012.505 Abstract | Full Text Retraction Top Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab A Gualberto, M L Hixon, D D Karp, D Li, S Green, M Dolled-Filhart, L G Paz-Ares, S Novello, J Blakely, C J Langer and M N Pollak Br J Cancer 2012 107: 2024; 10.1038/bjc.2012.497 Full Text Indexes Top Author Index for Volume 107 Br J Cancer 2012 107: 2025-2034; 10.1038/bjc.2012.532 Full Text Keyword Index for Volume 107 Br J Cancer 2012 107: 2035-2038; 10.1038/bjc.2012.533 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.